Related references
Note: Only part of the references are listed.Acute Adverse Reactions to Gadopentetate Dimeglumine and Gadobenate Dimeglumine: Experience With 32,659 Injections
Hani H. Abujudeh et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2010)
Multicenter Analysis of Tolerance and Clinical Safety of the Extracellular MR Contrast Agent Gadobenate Dimeglumine (MultiHance®)
C. U. Herborn et al.
ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN (2009)
Assessment of Adverse Reaction Rates to a Newly Approved MRI Contrast Agent: Review of 23,553 Administrations of Gadobenate Dimeglumine
Andrew G. Bleicher et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2008)
Anaphylactic shock after first exposure to gadoterate meglumine: Two case reports documented by positive allergy assessment
Frederic Hasdenteufel et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Nephrogenic Systemic Fibrosis in Japan: Advisability of Keeping the Administered Dose as Low as Possible
Yoshito Tsushima et al.
RADIOLOGY (2008)
Response to the FDA's May 23, 2007, nephrogenic systemic fibrosis update
Emanuel Kanal et al.
RADIOLOGY (2008)
Frequency and severity of acute allergic-like reactions to gadolinium-containing IV contrast media in children and adults
Jonathan R. Dillman et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2007)
Nephrogenic systemic fibrosis: Risk factors and incidence estimation
Elizabeth A. Sadowski et al.
RADIOLOGY (2007)
Anaphylaxis to gadobenate dimeglumine (Multihance((R))): A case report
Dimitrios C. Kalogeromitros et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2007)
Safety of gadobenate dimeglumine (MultiHance) - Summary of findings from clinical studies and postmorketing surveillance
FG Shellock et al.
INVESTIGATIVE RADIOLOGY (2006)
Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?
T Grobner
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Assessment of utilization and pharmacovigilance based on spontaneous adverse event reporting of gadopentetate dimeglumine as a magnetic resonance contrast agent after 45 million administrations and 15 years of clinical use
MV Knopp et al.
INVESTIGATIVE RADIOLOGY (2006)
Immediate reactions to contrast media: Mediator release and value of diagnostic testing
D Laroche
TOXICOLOGY (2005)
Release of inflammatory mediators from eosinophils following a hyperosmolar stimulus
ED Moloney et al.
RESPIRATORY MEDICINE (2003)